Erstellt von fchar99
Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals Inc.
WKN: A2AGYB / Symbol: ARWR / Name: Arrowhead Pharma / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
58,50 €
0,38 %
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at HC Wainwright from $80.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at Bank of America Corporation from $62.00 to $81.00. They now have a "buy" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at Royal Bank Of Canada from $52.00 to $80.00. They now have an "outperform" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Progressive Corp. diskutieren